Spider's web inspires removable implant that may control type 1 diabetes

January 2, 2018 by Tom Fleischman, Cornell University
Doctoral students Alan Chiu, left, and Duo An hold a sample of TRAFFIC (Thread-Reinforced Alginate Fiber for Islets enCapsulation). In the background, left to right, are Minglin Ma, Dan Luo, Meredith Silberstein and Dr. James Flanders. Credit: Cornell University

For the more than 1 million Americans who live with type 1 diabetes, daily insulin injections are literally a matter of life and death. And while there is no cure, a Cornell University-led research team has developed a device that could revolutionize management of the disease.

In Type 1 diabetes, insulin-producing pancreatic cell clusters (islets) are destroyed by the body's immune system. The research group, led by assistant professor Minglin Ma from the Department of Biological and Environmental Engineering, has devised an ingenious method for implanting hundreds of thousands of islet cells into a patient. They are protected by a thin hydrogel coating and, more importantly, the coated cells are attached to a polymer thread and can be removed or replaced easily when they have outlived their usefulness.

Transplantation of stem cell-derived, insulin-producing is an alternative to insulin therapy, but that requires long-term immunosuppressive drug administration. One well-researched approach to avoid the immune system's response is to coat and protect the cells in tiny hydrogel capsules, hundreds of microns in diameter. However, these capsules cannot be taken out of the body easily, since they're not connected to each other, and there are hundreds of thousands of them.

And the ability to remove the transplant is key because of its potential to form tumors.

"When they fail or die, they need to come out," Ma said. "You don't want to put something in the body that you can't take out. With our method, that's not a problem."

A schematic illustration of TRAFFIC (Thread-Reinforced Alginate Fiber for Islets enCapsulation), the implant device for control of type 1 diabetes developed in the lab of Cornell's Minglin Ma, biological and environmental engineering. Credit: Cornell University

Taking inspiration from the way water beads on a spider's web, Ma and his team first attempted to connect the islet cell-containing capsules through a string but realized that it would be better to put the hydrogel layer uniformly around a string instead. That string: an ionized calcium-releasing, nanoporous polymer thread.

This thread - which the group has dubbed TRAFFIC (Thread-Reinforced Alginate Fiber For Islets enCapsulation) - was inspired by a spider's web but, according to Ma, is even better because the hydrogel covers the thread uniformly.

"You don't have any gaps between capsules," he said. "With a spider's silk, you still have gaps between the water beads. In our case, gaps would be bad in terms of scar tissue and the like."

This therapy would involve minimally invasive laparoscopic surgery to implant approximately six feet of hydrogel-coated thread into the patient's peritoneal cavity.

TRAFFIC has received patent protection with the help of Danish pharmaceutical giant Novo Nordisk, which developed injectable insulin more than 90 years ago and is a collaborator on the paper. Other co-authors include professor Dan Luo in the Department of Biological and Environmental Engineering, postdoctoral researcher Wei Song, doctoral students Jason Lu and Yehudah Pardo, fiber science postdoc Dahua Shou, nutritional science professor Ling Qi and postdoc Yewei Ji.

Explore further: Research could treat Type I Diabetes by engineering pancreatic islets outside the body

Related Stories

Research could treat Type I Diabetes by engineering pancreatic islets outside the body

August 23, 2017
Tiny packets of cells called islets throughout the pancreas allow the organ to produce insulin. Type 1 diabetes—also known as juvenile diabetes - tricks the immune system into destroying these islets. Patients must take ...

Seaweed capsules may lead to an injection-free life for diabetic patients

December 28, 2015
Diabetes is one of the leading causes of death. Patients with type 1 diabetes have their insulin secreting cells destroyed by the immune system and require daily insulin injections. Pancreatic islet transplantation is an ...

Membrane for islets of Langerhans transplantations

October 4, 2017
Researchers at the University of Twente and other Dutch knowledge institutes have developed a membrane with which individual islets of Langerhans – insulin-producing cell clusters – can be encapsulated. The idea behind ...

Tiny bilirubin-filled capsules could improve survival of transplanted pancreatic cells

December 18, 2017
By encapsulating bilirubin within tiny nanoparticles, researchers from North Carolina State University and the Ohio State University have improved the survival rates of pancreatic islet cells in vitro in a low-oxygen environment. ...

Novel tissue-engineered islet transplant achieves insulin independence in type 1 diabetes

May 11, 2017
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered ...

New transplant technology could benefit patients with type 1 diabetes

June 5, 2017
Combining a new hydrogel material with a protein that boosts blood vessel growth could improve the success rate for transplanting insulin-producing islet cells into persons with type 1 diabetes. In an animal model, the technique ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Thirty-year study shows women who breastfeed for six months or more reduce their diabetes risk

January 16, 2018
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.